Connie Matsui's Net Worth
$50 Million
Who is Connie Matsui?
Connie Matsui has an estimated net worth of $50 Million. This is based on reported shares across multiple companies, which include SUTRO BIOPHARMA, INC., HALOZYME THERAPEUTICS, INC., ARTELO BIOSCIENCES, INC., and IDEC PHARMACEUTICALS CORP / DE.
SEC CIK
Connie Matsui's CIK is 0001236537
Past Insider Trading and Trends
2024 was Connie Matsui's most active year for acquiring shares with 9 total transactions. Connie Matsui's most active month to acquire stocks was the month of April. 2006 was Connie Matsui's most active year for disposing of shares, totalling 23 transactions. Connie Matsui's most active month to dispose stocks was the month of September. 2004 saw Connie Matsui paying a total of $1,383,340.00 for 243,960 shares, this is the most they've acquired in one year. In 2004 Connie Matsui cashed out on 498,291 shares for a total of $11,807,980.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SUTRO BIOPHARMA, INC. (STRO) Snapshot price: $4.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HALOZYME THERAPEUTICS, INC. (HALO) Snapshot price: $59.21
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.48% | 6.5K |
—
|
—
| 193.5K |
Apr 25
| |||
Form 4
| +4.51% | 8.06K |
—
|
—
| 187K |
May 5
| |||
Form 4
| -4.92% | -9.25K |
—
|
—
| 178.94K |
Nov 16
| |||
Form 4
| +3.41% | 6.21K |
—
|
—
| 188.19K |
May 5
| |||
Form 4
| -14.95% | -32.00K |
$40.38 | -$1,292,112.91 | 181.98K |
Nov 5
| |||
Form 4
| +2.51% | 5.23K |
—
|
—
| 213.98K |
May 5
| |||
Form 4
| -16.08% | -40.00K |
$27.06 | -$865,792.00 | 208.75K |
Sep 11 - Sep 14
| |||
Form 4
| +3.68% | 8.83K |
—
|
—
| 248.75K |
Apr 30
| |||
Form 4
| +5.34% | 12.17K |
—
|
—
| 239.92K |
May 2
| |||
Form 4
| -6.18% | -15.00K |
—
|
—
| 227.75K |
Dec 7
| |||
Form 4
| +4.46% | 10.36K |
—
|
—
| 242.75K |
May 2
| |||
Form 4
| -6.06% | -15.00K |
—
|
—
| 232.39K |
Sep 21
| |||
Form 4
| +4.21% | 10K |
$10.37 | $103,700.00 | 247.39K |
May 8
| |||
Form 4
| +6.33% | 14.13K |
—
|
—
| 237.39K |
May 4
| |||
Form 4
| +9.95% | 20.2K |
—
|
—
| 223.25K |
May 4
| |||
Form 4
| +10.93% | 20K |
$3.64 | $72,700.00 | 203.05K |
Sep 14
| |||
Form 4
| +7.76% | 13.18K |
—
|
—
| 183.05K |
May 6
| |||
Form 4
| +17.16% | 24.88K |
—
|
—
| 169.88K |
May 13
| |||
Form 4
| +16.00% | 20K |
—
|
—
| 145K |
May 16
| |||
Form 4
| +19.05% | 20K |
—
|
—
| 125K |
May 3
| |||
Form 4
| +23.53% | 20K |
—
| $20.00 | 105K |
May 5
| |||
Form 4
| +30.77% | 20K |
—
| $20.00 | 85K |
May 6
| |||
Form 4
| +44.44% | 20K |
—
| $20.00 | 65K |
May 7
| |||
Form 4
| +50.00% | 15K |
$4.94 | $74,100.00 | 45K |
May 8
| |||
Form 4
| +100.00% | 15K |
$10.37 | $155,550.00 | 30K |
May 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARTELO BIOSCIENCES, INC. (ARTL) Snapshot price: $1.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +277.78% | 41.67K |
$1.20 | $50,000.40 | 56.67K | ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IDEC PHARMACEUTICALS CORP / DE (BIIB) Snapshot price: $200.5
EVP, Corp. Strategy and Comm.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +23.20% | 4.3K |
—
|
—
| 22.84K |
Feb 12
| |||
Form 4
| -17.87% | -4.03K |
$48.94 | -$287,179.92 | 18.54K |
Feb 6
| |||
Form 4
|
—
|
0
|
$29.15 | -$1,076,507.42 | 22.57K |
Scheduled
|
Jan 16
| ||
Form 4/A
|
—
|
0
|
$32.98 | -$3,127,598.00 | 170.27K |
May 18
| |||
Form 4/A
|
—
|
0
|
$22.11 | -$1,115,359.23 | 11.67K |
Scheduled
|
Oct 12
| ||
Form 4
|
—
|
0
|
$26.62 | -$1,511,602.25 | 22.57K |
Scheduled
|
Oct 16
| ||
Form 4
| +72.60% | 9.49K |
$43.39 | -$347,380.34 | 22.57K |
Sep 14
| |||
Form 4
|
—
|
0
|
$25.19 | -$1,397,816.00 | 12.34K |
Scheduled
|
Jul 17
| ||
Form 4
|
—
|
0
|
$26.45 | -$1,497,948.00 | 96.83K |
Scheduled
|
Apr 28
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
| -5.32% | -2.29K |
—
|
—
| 40.77K |
Dec 23
| |||
Form 4/A
| -17.04% | -36.23K |
$22.11 | -$2,437,705.41 | 176.44K |
Scheduled
|
Oct 12
| ||
Form 4
|
—
|
0
|
$22.11 | -$1,115,359.23 | 136.82K |
Scheduled
|
Oct 12
| ||
Form 4
| -50.22% | -80.00K |
$36.22 | -$2,897,573.00 | 79.28K |
Scheduled
|
Jul 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
| -49.43% | -162.73K |
—
|
—
| 166.51K |
Dec 14 - Jan 10
| |||
Form 4
|
—
|
0
|
$32.98 | -$4,169,444.00 | 8K |
Aug 20
| |||
Form 4
|
—
|
0
|
$32.99 | -$3,127,598.00 | 441.99K |
May 18
| |||
Form 4
| +6.90% | 10.99K |
—
|
—
| 170.27K |
Feb 6
| |||
Form 4
| -5.94% | -10.05K |
—
|
—
| 159.28K |
Nov 26
| |||
Form 4
| +2.38% | 3.94K |
$7.72 | $30,396.63 | 169.34K |
Nov 25
| |||
Form 4
|
—
|
0
|
$20.23 | -$1,185,013.93 | 165.4K |
Nov 19
| |||
Form 4
| -3.86% | -6.63K |
$29.09 | $10,674.93 | 165.4K |
Mar 31 - Aug 20
| |||
| No matching records found | |||||||||